ESR1 and breast cancer: Then, the biologically active estradiol by binding to ERα facilitates “classical” and “nonclassical” genomic activities as well as rapid “non genomic” effects of the receptor to regulate downstream target protein expression involved in cell division, survival, angiogenesis, and invasion in breast cancer [147].